Background:

Evaluating analytical performance, quantitative sensitivity, and cross-platform consistency is critical for clinical and diagnostic DNA methylation assays. This community-wide international benchmarking study provides a thorough comparison of widely used detection methods.

Key Finding:

The independent multi-center evaluation demonstrates that Methylation-Sensitive High-Resolution Melting (MS-HRM) provides robust quantitative accuracy, exceptional reproducibility, and high cost-efficiency compared to complex sequencing workflows.

Conclusion:

The findings validate the technology behind MethylDetect’s assays in top-tier peer-reviewed literature, establishing MS-HRM as a high-performing protocol for both routine clinical diagnostics and biomarker development.